Index -
P/E 4.16
EPS (ttm) 0.49
Insider Own 9.83%
Shs Outstand 49.55M
Perf Week 5.73%
Market Cap 100.63M
Forward P/E -
EPS next Y -
Insider Trans 0.49%
Shs Float 44.70M
Perf Month -2.87%
Income 24.44M
PEG -
EPS next Q -
Inst Own 13.67%
Short Float 9.22%
Perf Quarter -23.68%
Sales 240.68M
P/S 0.42
EPS this Y -
Inst Trans -6.39%
Short Ratio 76.49
Perf Half Y -32.33%
Book/sh 3.47
P/B 0.58
EPS next Y -
ROA 1.51%
Short Interest 4.12M
Perf Year -10.57%
Cash/sh -
P/C -
EPS next 5Y -
ROE 28.22%
52W Range 1.64 - 3.69
Perf YTD -24.54%
Dividend Est. -
P/FCF 4.66
EPS past 5Y -
ROI 13.60%
52W High -44.99%
Beta 0.19
Dividend TTM -
Quick Ratio -
Sales past 5Y -0.19%
Gross Margin -
52W Low 23.78%
ATR (14) 0.16
Dividend Ex-Date -
Current Ratio 8.78
EPS Y/Y TTM 473.58%
Oper. Margin 10.88%
RSI (14) 40.97
Volatility 7.31% 8.25%
Employees 232
Debt/Eq 0.05
Sales Y/Y TTM 3.51%
Profit Margin 10.15%
Recom 3.00
Target Price 7.00
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q 220.24%
Payout 0.00%
Rel Volume 1.00
Prev Close 2.01
Sales Surprise -
EPS Surprise -
Sales Q/Q -0.61%
Earnings -
Avg Volume 53.85K
Price 2.03
SMA20 -1.46%
SMA50 -14.81%
SMA200 -27.50%
Trades
Volume 53,605
Change 1.00%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-10-08 Initiated
KeyBanc Capital Mkts
Buy
$8.50
Jan-11-08 Initiated
Oppenheimer
Buy
$6.50
Apr-03-24 07:00AM
Apr-02-24 04:01PM
07:00AM
Mar-18-24 01:00PM
Mar-14-24 04:01PM
07:00AM
Loading…
Mar-06-24 07:00AM
Mar-05-24 09:20AM
07:00AM
Feb-06-24 07:00AM
Jan-29-24 04:06AM
Jan-10-24 07:00AM
Jan-09-24 07:00AM
Jan-08-24 09:20AM
Dec-06-23 07:00AM
Dec-05-23 07:00AM
04:01PM
Loading…
Dec-04-23 04:01PM
Nov-06-23 04:01PM
Oct-04-23 07:00AM
Oct-03-23 07:00AM
Oct-02-23 04:01PM
Sep-06-23 08:00AM
Sep-05-23 07:00AM
Aug-16-23 04:01PM
Aug-15-23 10:20AM
Aug-04-23 09:20AM
Aug-01-23 09:20AM
Jul-17-23 09:20AM
Jul-10-23 04:48PM
Jun-16-23 11:36AM
Jun-12-23 07:07PM
08:48AM
Loading…
Jun-01-23 08:48AM
May-31-23 10:15AM
May-18-23 08:30AM
May-08-23 05:19PM
04:15PM
Mar-13-23 04:05PM
Mar-12-23 08:03AM
Mar-06-23 10:41AM
Feb-22-23 10:15AM
Dec-07-22 12:53PM
Dec-01-22 06:56AM
Nov-28-22 10:55AM
Nov-16-22 06:45PM
Nov-04-22 04:01PM
Nov-03-22 10:18AM
Oct-17-22 11:48AM
Oct-06-22 09:03AM
Aug-04-22 04:05PM
Jul-14-22 10:55AM
Jun-13-22 12:23PM
May-10-22 04:15PM
May-05-22 04:48PM
Apr-29-22 08:58AM
Apr-11-22 12:19AM
Mar-22-22 09:00AM
Mar-18-22 06:50PM
Mar-17-22 09:00AM
Mar-11-22 05:30PM
Jan-21-22 09:30AM
Dec-21-21 11:35AM
Dec-01-21 10:01AM
Nov-04-21 03:55PM
Aug-05-21 04:09PM
Aug-02-21 04:12PM
Jul-13-21 09:29AM
Jul-01-21 10:20AM
Jun-22-21 07:17PM
Jun-21-21 08:00AM
Jun-07-21 04:27PM
May-28-21 07:37AM
(The Wall Street Journal)
May-27-21 01:46PM
May-05-21 04:12PM
May-04-21 02:10AM
Apr-16-21 04:05PM
Mar-22-21 04:07PM
Mar-10-21 04:35PM
Feb-09-21 05:36PM
Nov-05-20 06:40AM
Nov-04-20 05:10PM
Aug-05-20 05:11PM
Jul-30-20 04:36PM
May-27-20 05:25PM
May-08-20 11:16AM
Mar-31-20 07:46AM
Mar-11-20 06:01PM
Feb-13-20 02:45PM
Jan-31-20 08:52AM
Dec-02-19 01:07PM
Nov-18-19 10:04AM
Sep-30-19 11:53AM
Sep-25-19 05:05PM
Aug-16-19 03:50PM
Jun-27-19 12:54PM
Jun-19-19 06:02AM
Dec-08-18 07:21PM
Nov-20-18 08:00AM
Aug-24-18 11:28AM
Aug-09-18 03:18PM
(American City Business Journals)
Jun-11-18 11:29AM
May-30-18 04:44PM
Citizens, Inc. is a holding company, which engages in the provision of insurance and reinsurance services. It operates through the Life Insurance and Home Service Insurance segments. The Life Insurance segment primarily issues ordinary whole life insurance and endowment policies in U.S. dollar-denominated amounts to foreign residents. The Home Service Insurance segment focuses on the life insurance needs of the middle- and lower-income markets. The company was founded by Harold Eugene Riley in 1969 and is headquartered in Austin, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MANESS TERRY SAM Director Apr 05 '24 Buy 2.14 1,000 2,137 15,947 Apr 08 05:28 PM MORGAN JAMES KEITH Director Mar 26 '24 Buy 2.11 5,899 12,469 61,965 Mar 27 03:01 PM MORGAN JAMES KEITH Director Mar 22 '24 Buy 1.98 1,101 2,180 56,066 Mar 25 11:52 AM Shields Gerald President & CEO Mar 21 '24 Buy 2.22 16,000 35,520 168,724 Mar 22 03:45 PM MORGAN JAMES KEITH Director Aug 09 '23 Buy 2.92 3,110 9,081 54,965 Aug 10 02:01 PM MORGAN JAMES KEITH Director Aug 08 '23 Buy 2.90 11,890 34,481 51,855 Aug 10 02:01 PM Claus Christopher W Director Jun 07 '23 Buy 2.28 15,909 36,198 40,176 Jun 09 03:35 PM Conklin Jeffery P. VP, CFO & Treasurer May 12 '23 Buy 1.93 14,000 27,020 115,782 May 16 12:32 PM Shields Gerald President & CEO May 11 '23 Buy 1.86 55,000 102,300 141,286 May 15 04:13 PM
Index RUT
P/E 7.33
EPS (ttm) 0.72
Insider Own 4.59%
Shs Outstand 73.53M
Perf Week -4.35%
Market Cap 389.66M
Forward P/E -
EPS next Y -0.07
Insider Trans -0.71%
Shs Float 70.41M
Perf Month -19.02%
Income 53.66M
PEG 0.37
EPS next Q 0.06
Inst Own 94.65%
Short Float 4.20%
Perf Quarter -32.13%
Sales 405.47M
P/S 0.96
EPS this Y -
Inst Trans -4.15%
Short Ratio 3.19
Perf Half Y -5.38%
Book/sh 5.86
P/B 0.90
EPS next Y -
ROA 11.57%
Short Interest 2.96M
Perf Year -23.26%
Cash/sh 3.94
P/C 1.34
EPS next 5Y 20.00%
ROE 13.51%
52W Range 4.38 - 8.45
Perf YTD -35.61%
Dividend Est. -
P/FCF 2.97
EPS past 5Y 17.20%
ROI 12.14%
52W High -37.51%
Beta 0.23
Dividend TTM -
Quick Ratio 8.57
Sales past 5Y 20.54%
Gross Margin 42.46%
52W Low 20.69%
ATR (14) 0.22
Dividend Ex-Date -
Current Ratio 9.77
EPS Y/Y TTM 393.46%
Oper. Margin 10.83%
RSI (14) 24.28
Volatility 2.96% 3.32%
Employees 638
Debt/Eq 0.03
Sales Y/Y TTM 4.64%
Profit Margin 13.23%
Recom 2.67
Target Price 7.55
Option/Short Yes / Yes
LT Debt/Eq 0.03
EPS Q/Q 25.99%
Payout 0.00%
Rel Volume 0.71
Prev Close 5.25
Sales Surprise 2.37%
EPS Surprise 165.75%
Sales Q/Q -38.35%
Earnings Feb 27 AMC
Avg Volume 926.01K
Price 5.28
SMA20 -10.17%
SMA50 -19.39%
SMA200 -17.81%
Trades
Volume 660,424
Change 0.57%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-03-23 Resumed
Evercore ISI
In-line
$5
Sep-22-21 Downgrade
Raymond James
Outperform → Mkt Perform
Aug-21-20 Initiated
Evercore ISI
Outperform
$22
Aug-10-20 Initiated
JP Morgan
Neutral
$18
Aug-10-20 Initiated
Citigroup
Buy
$18
Aug-07-20 Upgrade
Raymond James
Mkt Perform → Outperform
$16
Jun-25-20 Initiated
Lake Street
Buy
$19
Apr-21-20 Resumed
Stephens
Equal-Weight
$14
Oct-23-18 Resumed
Raymond James
Mkt Perform
Jul-16-18 Downgrade
Stephens
Overweight → Equal-Weight
Nov-02-17 Downgrade
Jefferies
Buy → Hold
Feb-09-17 Upgrade
Raymond James
Mkt Perform → Outperform
Jun-13-16 Downgrade
Raymond James
Outperform → Mkt Perform
Nov-05-15 Reiterated
Mizuho
Buy
$12 → $8
May-07-15 Downgrade
JMP Securities
Mkt Outperform → Mkt Perform
Jan-23-15 Reiterated
Mizuho
Buy
$10 → $12
Jun-12-14 Reiterated
Canaccord Genuity
Buy
$10 → $11
Jun-11-14 Reiterated
Mizuho
Buy
$9 → $10
Dec-21-12 Initiated
Mizuho
Buy
$9
Aug-08-12 Upgrade
Barrington Research
Mkt Perform → Outperform
$12.50
Show Previous Ratings
Mar-21-24 08:31AM
Feb-28-24 09:23AM
(Thomson Reuters StreetEvents) +9.96%
08:55AM
Feb-27-24 05:11PM
(Associated Press Finance)
04:48PM
04:05PM
Loading…
04:05PM
Feb-13-24 04:05PM
Feb-01-24 06:42PM
Jan-04-24 07:05AM
Dec-22-23 05:01AM
Nov-27-23 09:55AM
Nov-13-23 04:15PM
Nov-09-23 11:12AM
Nov-08-23 12:14PM
08:40AM
(Thomson Reuters StreetEvents)
06:50PM
Loading…
Nov-07-23 06:50PM
05:47PM
(Associated Press Finance)
04:59PM
04:05PM
Oct-23-23 04:05PM
Aug-09-23 06:02AM
Aug-05-23 08:52AM
Aug-04-23 11:45AM
(Thomson Reuters StreetEvents) +32.29%
Aug-03-23 05:55PM
04:58PM
(Associated Press Finance)
04:05PM
Jul-20-23 04:05PM
07:05AM
Jun-29-23 07:07AM
Jun-21-23 08:00PM
04:05PM
Loading…
Jun-13-23 04:05PM
Jun-08-23 11:03AM
Jun-01-23 06:29AM
May-16-23 06:08AM
May-12-23 07:12AM
(Simply Wall St.) -18.67%
May-11-23 11:03AM
(Thomson Reuters StreetEvents)
May-10-23 05:35PM
04:34PM
04:05PM
May-03-23 07:05AM
Apr-26-23 08:00PM
Apr-21-23 09:40AM
Apr-05-23 08:38AM
Mar-29-23 07:30AM
Mar-21-23 07:22AM
Mar-20-23 07:20AM
Mar-08-23 11:53AM
Feb-23-23 12:20PM
Feb-16-23 04:38PM
05:41AM
Feb-15-23 03:48PM
Feb-14-23 06:05PM
04:05PM
Feb-07-23 07:05AM
06:37AM
Dec-21-22 07:52AM
Dec-01-22 07:05AM
Nov-14-22 07:05AM
Nov-08-22 06:05PM
04:05PM
Nov-03-22 09:15AM
Nov-02-22 07:05AM
Nov-01-22 07:05AM
Oct-07-22 09:14AM
Oct-01-22 10:30AM
Sep-28-22 10:28AM
07:05AM
Sep-20-22 04:05PM
Sep-14-22 07:05AM
Aug-31-22 06:29AM
Aug-14-22 08:28AM
Aug-09-22 07:25PM
04:05PM
Aug-02-22 07:05AM
Jul-28-22 07:05AM
Jul-14-22 08:42AM
07:05AM
Jun-14-22 08:31AM
Jun-08-22 04:05PM
May-25-22 07:05AM
May-23-22 04:05PM
May-17-22 07:05AM
May-10-22 06:55PM
04:05PM
May-04-22 06:45PM
May-03-22 04:05PM
Apr-24-22 10:21AM
Apr-07-22 07:05AM
Mar-31-22 07:05AM
Mar-22-22 04:05PM
Feb-23-22 04:05PM
Feb-16-22 04:05PM
Jan-31-22 07:54AM
07:05AM
Jan-25-22 07:05AM
Jan-24-22 10:04AM
Jan-19-22 05:38PM
Jan-13-22 04:05PM
Jan-06-22 11:09AM
(American City Business Journals)
Jan-05-22 04:24PM
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Weber Kathleen Gallagher Chief Product Officer Dec 19 '23 Option Exercise 5.71 4,129 23,597 278,829 Dec 21 04:04 PM Weber Kathleen Gallagher Chief Product Officer Dec 19 '23 Sale 8.05 24,129 194,219 254,700 Dec 21 04:04 PM Anthony Michele Marie SVP Finance & CAO Aug 15 '23 Option Exercise 5.71 1,758 10,038 87,946 Aug 17 04:27 PM Anthony Michele Marie SVP Finance & CAO Aug 15 '23 Sale 6.50 1,758 11,427 86,188 Aug 17 04:27 PM McGrath Kenneth J Chief Financial Officer May 30 '23 Buy 4.93 100,000 492,810 285,512 May 31 04:14 PM
Index RUT
P/E -
EPS (ttm) -0.43
Insider Own 81.28%
Shs Outstand 115.10M
Perf Week -0.53%
Market Cap 1.30B
Forward P/E 15.34
EPS next Y 0.74
Insider Trans 0.00%
Shs Float 21.53M
Perf Month -1.39%
Income -49.10M
PEG -
EPS next Q 0.01
Inst Own 15.46%
Short Float 3.77%
Perf Quarter 26.73%
Sales 1.67B
P/S 0.78
EPS this Y 191.47%
Inst Trans 4.84%
Short Ratio 3.10
Perf Half Y 58.68%
Book/sh 7.02
P/B 1.61
EPS next Y 87.74%
ROA -2.60%
Short Interest 0.81M
Perf Year 21.31%
Cash/sh 1.71
P/C 6.62
EPS next 5Y -9.48%
ROE -5.56%
52W Range 6.16 - 12.48
Perf YTD 13.98%
Dividend Est. 0.38 (3.35%)
P/FCF -
EPS past 5Y -
ROI -3.87%
52W High -9.21%
Beta 1.19
Dividend TTM 0.76 (6.71% )
Quick Ratio 1.49
Sales past 5Y 0.61%
Gross Margin 9.89%
52W Low 83.93%
ATR (14) 0.36
Dividend Ex-Date Mar 04, 2024
Current Ratio 3.01
EPS Y/Y TTM -147.16%
Oper. Margin -3.58%
RSI (14) 49.48
Volatility 2.37% 3.03%
Employees 2196
Debt/Eq 0.57
Sales Y/Y TTM -13.66%
Profit Margin -2.95%
Recom 3.67
Target Price 9.67
Option/Short Yes / Yes
LT Debt/Eq 0.57
EPS Q/Q 73.26%
Payout -
Rel Volume 0.65
Prev Close 11.29
Sales Surprise 5.55%
EPS Surprise 64.36%
Sales Q/Q 16.85%
Earnings Mar 06 AMC
Avg Volume 261.93K
Price 11.33
SMA20 -3.98%
SMA50 8.42%
SMA200 25.48%
Trades
Volume 171,252
Change 0.35%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-13-22 Initiated
Goldman
Sell
$9
Mar-28-17 Downgrade
Standpoint Research
Buy → Hold
Mar-14-17 Reiterated
Barclays
Underweight
$7 → $12
Aug-28-15 Reiterated
Barclays
Underweight
$11 → $8
Aug-18-15 Reiterated
Deutsche Bank
Hold
$13 → $8
Feb-03-14 Initiated
Barclays
Underweight
$12
May-10-13 Reiterated
Deutsche Bank
Hold
$18 → $16
Mar-13-13 Reiterated
Argus
Hold
$14 → $18
Jan-03-13 Downgrade
Oppenheimer
Outperform → Perform
Mar-02-12 Initiated
Standpoint Research
Buy
$32
Feb-22-12 Downgrade
Deutsche Bank
Buy → Hold
$24 → $23
May-05-11 Reiterated
Deutsche Bank
Buy
$60 → $75
Mar-08-11 Reiterated
Deutsche Bank
Buy
$50 → $60
Feb-11-11 Reiterated
Oppenheimer
Outperform
$52 → $57
Dec-03-10 Reiterated
UBS
Buy
$27 → $25
Dec-02-10 Initiated
Deutsche Bank
Buy
$50
Nov-30-10 Initiated
BB&T Capital Mkts
Hold
Nov-08-10 Initiated
Deutsche Bank
Buy
$50
Show Previous Ratings
Apr-08-24 08:16AM
Apr-05-24 11:30AM
Apr-04-24 12:00PM
Apr-02-24 08:50AM
Apr-01-24 08:23AM
08:09AM
Loading…
Mar-20-24 08:09AM
Mar-19-24 12:00PM
Mar-15-24 09:40AM
Mar-13-24 12:16PM
Mar-12-24 05:22AM
Mar-07-24 01:52PM
01:28PM
08:35AM
Mar-06-24 10:52PM
04:28PM
(Associated Press Finance)
04:15PM
Loading…
04:15PM
Feb-21-24 04:15PM
Feb-05-24 07:02PM
Jan-25-24 07:56AM
Jan-23-24 06:21AM
Dec-18-23 06:15AM
Nov-07-23 09:18PM
Nov-03-23 07:19AM
Nov-02-23 06:35PM
04:42PM
(Associated Press Finance)
04:15PM
Oct-25-23 04:15PM
Oct-11-23 01:18PM
Sep-01-23 11:31AM
Aug-06-23 08:04AM
06:50AM
Loading…
Aug-04-23 06:50AM
Aug-02-23 07:05PM
06:03PM
04:17PM
04:15PM
Jul-26-23 10:02AM
Jul-25-23 07:15AM
Jun-08-23 05:55AM
Jun-06-23 01:50PM
Jun-05-23 07:50AM
Jun-02-23 11:31AM
May-22-23 08:32AM
May-21-23 08:14AM
May-17-23 04:15PM
May-05-23 06:02AM
May-04-23 06:11AM
May-03-23 08:15PM
07:09PM
04:15PM
Apr-17-23 09:19PM
Apr-10-23 06:14AM
Mar-26-23 10:21AM
Mar-16-23 02:13PM
Mar-12-23 09:18AM
Mar-10-23 09:37AM
Mar-09-23 12:28PM
06:35AM
Mar-08-23 05:45PM
04:15PM
Feb-27-23 09:15AM
Feb-26-23 07:02AM
Feb-22-23 04:15PM
Feb-21-23 06:35PM
Feb-16-23 08:15AM
Feb-07-23 06:15PM
Jan-27-23 06:45AM
Jan-06-23 11:11AM
Dec-02-22 11:31AM
Nov-28-22 06:38AM
Nov-10-22 06:59AM
Nov-02-22 06:35PM
04:15PM
Oct-31-22 11:05AM
Oct-27-22 10:03AM
Oct-26-22 04:15PM
Oct-15-22 08:04AM
Sep-27-22 09:53AM
(Simply Wall St.) -12.36%
Sep-02-22 11:31AM
Aug-23-22 06:37PM
Aug-16-22 11:45AM
Aug-13-22 09:13AM
Aug-10-22 07:55AM
Aug-03-22 06:05PM
04:15PM
04:15PM
Aug-02-22 07:15AM
Jul-30-22 08:41AM
Jul-29-22 11:45AM
Jul-28-22 06:05PM
11:13AM
05:45AM
Jul-27-22 01:54PM
Jul-21-22 07:25AM
Jul-18-22 06:23AM
Jul-15-22 09:55AM
07:43AM
Jul-13-22 11:45AM
Jul-12-22 10:41AM
Jul-06-22 09:40AM
Jul-01-22 10:46AM
Kronos Worldwide, Inc. engages in the production and marketing of value-added titanium dioxide pigments. Its products are used for coatings and inks, plastics, paper and paper laminates, man-made fibers, health, food, and beauty, and ceramic, glass, and welding rods applications. The firm also offers assistance in pigment selection, consultation, on-site training, testing on lab scale equipment, and weathering tests technical services. The company was founded in 1916 and is headquartered in Dallas, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hanley Bryan A. Senior VP and Treasurer Mar 11 '24 Buy 10.65 1,000 10,652 2,500 Mar 12 08:20 AM NACE ANDREW B Executive Vice President Aug 07 '23 Buy 9.17 2,728 25,000 15,453 Aug 09 10:34 AM NACE ANDREW B Executive Vice President May 24 '23 Buy 8.31 4,000 33,221 12,725 May 24 03:21 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite